2022 International Congress Archives - Page 126 of 153

Sex differences in vascular risk factors for Parkinson’s disease

K. Tsutsumi, E. Shah, A. Siddiqui, I. Attaripour (Orange, USA)
Sex Modulates Cognitive Association of Lewy Body Pathology

E. Bayram, K. Wang, A. Tsai, D. Coughlin, I. Litvan (La Jolla, USA)
Sex-specific factor analysis-derived profile of neuropsychiatric symptoms predicting dementia conversion in Parkinson’s disease

Y. Lee, SW. Kang, SH. Yoon, K. Baik, HK. Na, YH. Sohn, PH. Lee (Seoul, Republic of Korea)
Sexual dysfunctions in Parkinson’s disease and their influence on partnership – data from the PRISM study

T. Kinateder, D. Marinho, L. Hatzler, D. Gruber, G. Ebersbach, F. Gandor (Beelitz-Heilstaetten, Germany)
Shared molecular genetic factors influence brain morphometry and Parkinson’s disease risk

L. Garcia-Marin, P. Reyes, Z. Ceja, N. Ogonowski, B. García-Vilchis, A. Ruiz-Contreras, D. Vazquez-Guevara, S. Alcauter, E. Morelos, A. Medina-Rivera, B. Mitchell, M. Rentería (Brisbane, Australia)
Short and long-term cental action of botulinum neurotoxin treatment in laryngeal dystonia

L. O'Flynn, K. Simonyan (Boston, USA)
Short and long-term Impact of Covid-19 Pandemic on motor and non-motor symptoms in Leucine-rich repeat kinase2 (LRRK2) associated Parkinson’s disease

A. Nasri, S. Mrabet, Y. Abida, A. Souissi, A. Gharbi, A. Gargouri, I. Kacem, R. Gouider (Tunis, Tunisia)
Short report in a dystonia cohort patients with implanted DBS systems

B. Mukhammedaminov, A. Sufianov, A. Orlov (Tashkent, Uzbekistan)
Short-latency afferent inhibition for the assessment of cholinergic degeneration in Parkinson’s disease

E. D'Angremont, I. Zijdewind, S. Vander Zee, E. de Vries, T. van Laar, I. Sommer (Groningen, Netherlands)
Sigma Absolute Spectral Power is Associated with Depression in Parkinson’s Disease

A. Memon, C. Catiul, Z. Irwin, J. Pilkington, A. Joop, R. Memon, K. Wood, G. Cutter, S. Miocinovic, A. Amara (Birmingham, USA)